2m 2m 2m 2m 2m 2m 2m
BEAM THERAPEUTIC (BEAM)
NASDAQ
$33.30+$0.09 (+0.29%)
Price as of Jun 23, 2026 7:59 PM EDT- $3.7BMarket Cap
- 112.63%1-Year Change
- BiotechnologyIndustry
BEAM THERAPEUTIC (BEAM)
$33.30+$0.09 (+0.29%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 139.7M +120.01% | 63.5M -83.18% | 377.7M +520.01% | 60.9M +17.51% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 139.7M +120.01% | 63.5M -83.18% | 377.7M +520.01% | 60.9M +17.51% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -409.6M +11.44% | -367.6M -15.96% | -437.4M +40.37% | -311.6M -19.50% | |
Depreciation and Amortization Expense | 22.3M +1.68% | 21.9M +9.56% | 20.0M +41.46% | 14.1M +89.87% | |
Total Operating Expenses | 523.4M +9.26% | 479.1M -13.55% | 554.2M +38.76% | 399.4M -10.11% | |
Operating Profit | -383.7M -7.67% | -415.6M +135.47% | -176.5M -47.86% | -338.5M -13.76% | |
Interest Income | 43.7M -10.92% | 49.1M N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 43.7M -10.92% | 49.1M N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 303.7M +681.43% | 38.9M -14.25% | 45.3M -42.12% | 78.3M +258.73% | |
Income before Taxes | -80.0M -78.77% | -376.7M +187.21% | -131.2M -49.59% | -260.2M -29.80% | |
Income Taxes | 0 -100.00% | 39,000 -97.14% | 1.4M -59.94% | 3.4M N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -80.0M -78.77% | -376.7M +184.28% | -132.5M -54.16% | -289.1M -22.00% | |
Net Income from Continuing Operations Applicable to Common | -80.0M -78.77% | -376.7M +184.28% | -132.5M -54.16% | -289.1M -22.00% | |
Basic EPS and Net Income | -0.81 -82.31% | -4.58 +166.28% | -1.72 -58.35% | -4.13 -28.42% | |
Diluted EPS and Net Income | -0.81 -82.31% | -4.58 +166.28% | -1.72 -58.35% | -4.13 -28.42% | |
Basic Weighted Average Shares | 98.9M +20.16% | 82.3M +6.69% | 77.2M +10.19% | 70.0M +9.01% | |
Diluted Weighted Average Shares | 98.9M +20.16% | 82.3M +6.69% | 77.2M +10.19% | 70.0M +9.01% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 294.9M +4.60% | 282.0M -35.31% | 435.9M +87.27% | 232.8M -58.43% | |
Short-Term Investments | 950.3M N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 1.2B +341.62% | 282.0M -35.31% | 435.9M +87.27% | 232.8M -58.43% | |
Total Current Assets | 1.3B +44.47% | 878.1M -27.49% | 1.2B +10.81% | 1.1B -14.15% | |
Accumulated Depreciation | 94.1M +30.54% | 72.1M +43.69% | 50.2M +66.33% | 30.2M +87.61% | |
Property and Plant and Equipment and Net | 104.5M -6.20% | 111.4M -10.84% | 125.0M +8.08% | 115.6M +37.22% | |
Total Long-Term Assets | 634,000 -49.44% | 1.3M -41.57% | 2.1M +11.13% | 1.9M +12.01% | |
Total Assets | 1.5B +34.19% | 1.1B -24.38% | 1.5B +8.79% | 1.3B -9.00% | |
Income Taxes Payable | N/A N/A | N/A N/A | 43.3M N/A | N/A N/A | |
Total Short-Term Debt | 400.0M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 96.9M -46.76% | 182.1M -11.43% | 205.6M -8.06% | 223.6M +4.76% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 173,000 -65.67% | 504,000 +69.13% | 298,000 +33.04% | 224,000 -91.98% | |
Total Liabilities | 242.8M -34.42% | 370.3M -22.60% | 478.4M -21.35% | 608.2M -6.09% | |
Retained Earnings | -1.6B +4.76% | -1.6B +31.66% | -1.2B +12.53% | -1.1B +37.63% | |
Total Stockholders Equity | 1.2B +68.82% | 733.5M -25.25% | 981.3M +33.79% | 733.5M -11.28% | |
Total Shares Outstanding | 101.7M +21.66% | 83.6M +2.45% | 81.6M +14.53% | 71.3M +4.22% | |
Cash Flow | |||||
Cash from Operating Activities | -345.1M -0.62% | -347.2M +132.75% | -149.2M -762.29% | 22.5M +133.99% | |
Capital Expenditures | 14.9M +67.07% | 8.9M -73.48% | 33.7M -31.09% | 49.0M +4.57% | |
Cash from Investing Activities | -121.4M -165.64% | 185.0M +157.53% | 71.8M +115.57% | -461.3M +56.84% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 478.0M +6,079.54% | 7.7M -97.20% | 276.4M +147.74% | 111.6M -85.24% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -274.57% -58.03% | -654.25% +1,300.22% | -46.73% -91.59% | -555.61% -26.60% | |
Return on Assets | -6.19% -78.94% | -29.39% +210.65% | -9.46% -53.92% | -20.53% -46.65% | |
Return on Equity | -8.11% -81.53% | -43.94% +184.26% | -15.46% -58.29% | -37.06% -46.39% | |
Revenue Growth | 120.01% +244.27% | -83.18% -116.00% | 520.01% +2,870.39% | 17.51% -99.99% | |
Current Ratio | 13.09 +171.36% | 4.82 -18.13% | 5.89 +20.53% | 4.89 -18.05% | |
Cash Ratio | 3.04 +96.47% | 1.55 -26.97% | 2.12 +103.70% | 1.04 -60.32% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow